Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT01266720
Eligibility Criteria:
Inclusion Criteria:
* locally advanced or metastatic pancreatic cancer precluding curative surgical resection and recurrent pancreatic cancer
* Measurable disease by CT scan
* ECOG performance status 0-2
* Life expectancy \> 3 months
* laboratory values as follows: 2,000/mm3 \< WBC \< 15,000/mm3, Platelet count \>75,000/mm3, Total Bilirubin \<1.5 mg/dl, Asparate transaminase \<150IU/L, Alanine transaminase \< 150 IU/L, Creatinine \< 3.0mg/dl
* HLA-A\*0201
* Able and willing to give valid written infromed consent
Exclusion Criteria:
* Pregnancy (women of childbearing potential: Refusal or inability to use effective means of contraception)
* Breast-feeder
* Active or uncontrolled infection
* Prior chemotherapy, radiation therapy, or immunotherapy within 4 weeks
* Serious or uncured wound
* Active or uncontrolled other malignancy
* Steroids or immunosuppressing agent dependent status
* Interstitial pneumonia
* Ileus
* Decision of unsuitableness by principal investigator or physician-in-charge
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT01266720
Study Brief:
Protocol Section:
NCT01266720